"Turpentine VC" | Venture Capital and Investing  cover image

E61: Rabois, Bartlett, Ryan, and Weinberg on AI, Gambling, and Healthcare

"Turpentine VC" | Venture Capital and Investing

CHAPTER

Navigating the FDA's Approval Labyrinth

This chapter explores the intricate balance of safety and timely access in the FDA's drug approval process, emphasizing the ethical dilemmas inherent in pharmaceutical decisions. It highlights specific cases, such as Pfizer's withdrawal of a sickle cell treatment, to illustrate the risks involved in drug development and distribution. The discussion also encourages a critical evaluation of personal responsibility and the understanding of medical risks in healthcare.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner